| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,134 |
1,846 |
$311K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,243 |
1,035 |
$234K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,121 |
1,191 |
$220K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,011 |
1,151 |
$213K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
544 |
471 |
$149K |
| 80053 |
Comprehensive metabolic panel |
3,957 |
3,085 |
$123K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,609 |
3,456 |
$93K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
534 |
464 |
$45K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,708 |
3,083 |
$45K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
766 |
696 |
$44K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,748 |
428 |
$40K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
402 |
395 |
$33K |
| 86140 |
|
978 |
773 |
$21K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
17 |
13 |
$20K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
221 |
132 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
3,018 |
2,130 |
$18K |
| 70450 |
Computed tomography, head or brain; without contrast material |
24 |
24 |
$12K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
143 |
129 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
243 |
167 |
$11K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
132 |
99 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
124 |
60 |
$11K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
569 |
545 |
$11K |
| 84484 |
|
214 |
126 |
$10K |
| 84443 |
Thyroid stimulating hormone (TSH) |
685 |
652 |
$10K |
| 71045 |
Radiologic examination, chest; single view |
136 |
121 |
$9K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
48 |
45 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
77 |
71 |
$8K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
192 |
181 |
$8K |
| 81001 |
|
648 |
548 |
$7K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
81 |
76 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
108 |
81 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
276 |
251 |
$4K |
| 87581 |
|
63 |
60 |
$4K |
| 87486 |
|
63 |
60 |
$4K |
| 84145 |
|
89 |
76 |
$3K |
| 97161 |
|
55 |
52 |
$3K |
| 83605 |
|
113 |
95 |
$3K |
| 85610 |
|
263 |
212 |
$3K |
| 81003 |
|
252 |
194 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
272 |
211 |
$1K |
| 83735 |
|
49 |
39 |
$1K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
50 |
46 |
$1K |
| 87400 |
|
28 |
14 |
$1K |
| 85730 |
|
34 |
27 |
$952.10 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
190 |
161 |
$732.20 |
| 36416 |
|
94 |
55 |
$724.96 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
30 |
27 |
$723.68 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
29 |
24 |
$549.37 |
| J2704 |
Injection, propofol, 10 mg |
159 |
103 |
$535.18 |
| 85027 |
|
33 |
28 |
$457.10 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
73 |
71 |
$405.34 |
| 87186 |
|
15 |
14 |
$403.20 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
97 |
69 |
$308.18 |
| 84439 |
|
16 |
16 |
$307.02 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
13 |
$259.14 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
39 |
37 |
$221.20 |
| 80061 |
Lipid panel |
12 |
12 |
$194.56 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
17 |
12 |
$88.11 |